Click a link below to view the mailing archive as if it had been sent to you.
2018-04-30 12:15 | | Sermo's 'Yelp for drugs' platform chalks up 665K doctor reviews in just 1 year and more... |
2018-04-30 00:15 | | AbbVie's First Quarter: Trying to Replace Humira Sales and more... |
2018-04-29 00:15 | | 4 Huge Pharma Deals in 4 Months Is Just the Beginning and more... |
2018-04-28 12:15 | | UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis and more... |
2018-04-28 00:15 | | The hepatitis C duopoly and more... |
2018-04-27 12:15 | | Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy and more... |
2018-04-27 00:15 | | Hey, Takeda shareholders: Shire's Q1 may ease some buyout worries, analysts say and more... |
2018-04-26 12:15 | | Roche flags first case of anti-drug antibodies that forced a patient to drop would-be blockbuster Hemlibra and more... |
2018-04-26 00:15 | | Amgen focuses on migraine launch as growth remains slow and more... |
2018-04-25 12:15 | | AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study and more... |
2018-04-25 00:15 | | Immunotherapies, biosimilars to dominate next week of earnings and more... |
2018-04-24 12:15 | | Biogen stock drops 2% after Q1 sales miss and more... |
2018-04-24 00:15 | | FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses and more... |
2018-04-23 04:30 | | Fresenius SE Walks Away from $4.3 Billion Takeover of Akorn and more... |
2018-04-22 17:06 | | IMPORTANT: Change to our daily newsletter |
2018-04-22 04:30 | | Bellicum Pharmaceuticals Rakes in $69 Million - Closes Public Offering and more... |
2018-04-21 04:30 | | Lessons learned from going live on Facebook with a branded drug and more... |
2018-04-20 04:30 | | FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy and more... |
2018-04-19 04:30 | | Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso and more... |
2018-04-18 12:15 | | Abbott shares down on shrinking Q1 profits and more... |
2018-04-18 00:15 | | Healthcare on the Hill - Transparent Health Care Pricing Act of 2018 (H. R. 4808) and more... |
2018-04-17 12:15 | | Roche gets double dose of good Hemlibra news with FDA breakthrough, ICER backing and more... |
2018-04-17 00:15 | | Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer and more... |
2018-04-16 12:15 | | Boston Scientific acquires NVision Medical in $275m deal and more... |
2018-04-16 01:32 | | CP Weekly April 15 2018 |
2018-04-16 00:15 | | We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated and more... |
2018-04-15 00:15 | | EpiPen shortages seen in Canada, UK but U.S. supply intact and more... |
2018-04-14 00:15 | | Mallinckrodt used 'dirty data' to snow payers on Acthar, whistleblower suit says and more... |
2018-04-13 12:15 | | Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device and more... |
2018-04-13 00:15 | | PCSK9s appear to be meeting less payer resistance and more... |
2018-04-12 12:15 | | Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma and more... |
2018-04-12 00:15 | | Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS and more... |
2018-04-11 12:15 | | Alexion buying Swedish biotech for $855 million to broaden rare disease pipeline and more... |
2018-04-11 00:15 | | Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study and more... |
2018-04-10 12:15 | | Pfizer heads to the Hudson, signs 20-year lease at posh new NYC headquarters and more... |
2018-04-10 00:15 | | FDA puts restrictions on Bayer birth control implant but no recall and more... |
2018-04-09 12:15 | | Celgene on biotech hunt with Agios, Jounce in crosshairs: FT and more... |
2018-04-09 00:15 | | Major restructuring with staff cuts in US for Teva and more... |
2018-04-08 23:40 | | CP Weekly April 8 2018 |
2018-04-08 12:15 | | [video]Will Shire Be Bought Out? and more... |
2018-04-07 12:15 | | Abbott disputes ‘flawed and inaccurate’ proxy report over CEO’s pay and more... |
2018-04-07 00:15 | | Incyte's Horrible News Derails a Promising Class of Cancer Drugs and more... |
2018-04-06 12:15 | | Merck gets a lift, Pfizer a ding as analysts assess immuno-oncology, M&A outlook and more... |
2018-04-06 00:15 | | Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test and more... |
2018-04-05 12:15 | | Hopes rise for Shire sale as Takeda CEO discusses case for deal and more... |
2018-04-05 00:15 | | Amgen's money-back offer on Repatha isn't all that meaningful, researchers find and more... |
2018-04-04 12:15 | | Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib and more... |
2018-04-04 00:15 | | Will Blincyto's Expanded FDA Approval Open the Door for Wider Use of MRD as a Biomarker or Endpoint? and more... |
2018-04-03 12:15 | | Justice Dept. says it will seek to join settlement talks in opioid lawsuits and more... |
2018-04-03 00:15 | | Citizen Petition Watch - Increased Activity Around Ditropan XL and more... |
2018-04-02 12:15 | | Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise and more... |